In utero exposure to perfluorooctanoate (PFOA) or perfluorooctane sulfonate (PFOS) did not increase body weight or intestinal tumorigenesis in multiple intestinal neoplasia (Min/+) mice

Environmental Research

Volumn 132, Issue , 2014, Pages 251-263

  Ngo, Ha Thi ^a   Hetland, Ragna Bogen ^a   Sabaredzovic, Azemira ^a   Haug, Line Småstuen ^a   Steffensen, Inger Lise ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

In utero exposure; Intestinal tumorigenesis; Obesogen; Perfluorooctane sulfonate; Perfluorooctanoate

Indexed keywords

GLUCOSE; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID;

BODY MASS; ECOTOXICOLOGY; ESTER; FOOD INTAKE; GLUCOSE; POLLUTION EXPOSURE; RODENT; TOXICITY TEST; TUMOR; WEIGHT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; COLON CARCINOGENESIS; COLON TUMOR; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; FOOD INTAKE; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; INCIDENCE; LIVER WEIGHT; MALE; MOUSE; MULTIPLE CANCER; MULTIPLE INTESTINAL NEOPLASIA; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROGENY; SMALL INTESTINE TUMOR; SURVIVAL RATE; WILD TYPE;

IN UTERO EXPOSURE; INTESTINAL TUMORIGENESIS; MIN/+ MOUSE; OBESOGEN; PERFLUOROOCTANE SULFONATE; PERFLUOROOCTANOATE;

ALKANESULFONIC ACIDS; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CAPRYLATES; CARCINOGENESIS; EATING; FEMALE; FLUOROCARBONS; INTESTINAL NEOPLASMS; LIVER; MALE; MICE; MICE, INBRED C57BL; OBESITY; ORGAN SIZE; PREGNANCY; REPRODUCTION; SPLEEN;

EID: 84900026566     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2014.03.033     Document Type: Article

References (42)

1. Abbott B.D., Wood C.R., Watkins A.M., Tatum-Gibbs K., Das K.P., Lau C. Effects of perfluorooctanoic acid (PFOA) on expression of peroxisome proliferator-activated receptors (PPAR) and nuclear receptor-regulated genes in fetal and postnatal CD-1 mouse tissues. Reprod. Toxicol. 2012, 33:491-505.
2. Andreassen A., Møllersen L., Vikse R., Steffensen I.-L., Mikalsen A., Paulsen J.E., Alexander J. One dose of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) or 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) induces tumours in Min/+ mice by truncation mutations or LOH in the Apc gene. Mutat. Res. 2002, 517:157-166.
3. Barker D.J., Osmond C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet 1986, 1:1077-1081.
4. Biegel L.B., Hurtt M.E., Frame S.R., O'Connor J.C., Cook J.C. Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats. Toxicol. Sci. 2001, 60:44-55.
5. Buck R.C., Franklin J., Berger U., Conder J.M., Cousins I.T., de Voogt P., Jensen A.A., Kannan K., Mabury S.A., van Leeuwen S.P. Perfluoroalkyl and polyfluoroalkyl substances in the environment: terminology, classification, and origins, Integr. Environ. Assess. Manag. 2011, 7:513-541.
6. Butenhoff J.L., Chang S.C., Olsen G.W., Thomford P.J. Chronic dietary toxicity and carcinogenicity study with potassium perfluorooctanesulfonate in Sprague Dawley rats. Toxicology 2012, 293:1-15.
7. Butenhoff J.L., Kennedy G.L., Chang S.C., Olsen G.W. Chronic dietary toxicity and carcinogenicity study with ammonium perfluorooctanoate in Sprague-Dawley rats. Toxicology 2012, 298:1-13.
8. Calle E.E., Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer 2004, 4:579-591.
9. De Coster S., van Larebeke N. Endocrine-disrupting chemicals: associated disorders and mechanisms of action. J. Environ. Public Health 2012, 2012:713696.
10. EFSA, 2008. Perfluorooctane Sulfonate (PFOS), Perfluorooctanoic Acid (FPOA) and Their Salts. Scientific Opinion of the Panel on Contaminants in the Food chain. Question N° EFSA-Q-2004-163. Adopted on 21 February 2008, EFSA J., 653, 1-131. European Food Safety Authority.
11. Elobeid M.A., Allison D.B. Putative environmental-endocrine disruptors and obesity: a review. Curr. Opin. Endocrinol. Diabetes Obes. 2008, 15:403-408.
12. Emmett E.A., Shofer F.S., Zhang H., Freeman D., Desai C., Shaw L.M. Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources. J. Occup. Environ. Med. 2006, 48:759-770.
13. Fenton S.E., Reiner J.L., Nakayama S.F., Delinsky A.D., Stanko J.P., Hines E.P., White S.S., Lindstrom A.B., Strynar M.J., Petropoulou S.S. Analysis of PFOA in dosed CD-1 mice. Part 2. Disposition of PFOA in tissues and fluids from pregnant and lactating mice and their pups. Reprod. Toxicol. 2009, 27:365-372.
14. Fromme H., Tittlemier S.A., Volkel W., Wilhelm M., Twardella D. Perfluorinated compounds-exposure assessment for the general population in Western countries. Int. J. Hyg. Environ. Health 2009, 212:239-270.
15. Gluckman P.D., Hanson M.A., Beedle A.S. Early life events and their consequences for later disease: a life history and evolutionary perspective. Am. J. Hum. Biol. 2007, 19:1-19.
16. Grün F., Blumberg B. Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology 2006, 147:S50-S55.
17. Grün F., Blumberg B. Endocrine disrupters as obesogens. Mol. Cell. Endocrinol. 2009, 304:19-29.
18. Halldorsson T.I., Rytter D., Haug L.S., Bech B.H., Danielsen I., Becher G., Henriksen T.B., Olsen S.F. Prenatal exposure to perfluorooctanoate and risk of overweight at 20 years of age: a prospective cohort study. Environ. Health Perspect. 2012, 120:668-673.
19. Haug L.S., Thomsen C., Becher G. A sensitive method for determination of a broad range of perfluorinated compounds in serum suitable for large-scale human biomonitoring. J. Chromatogr. A 2009, 1216:385-393.
20. Heindel J.J., vom Saal F.S. Role of nutrition and environmental endocrine disrupting chemicals during the perinatal period on the aetiology of obesity. Mol. Cell. Endocrinol. 2009, 304:90-96.
21. Hines E.P., White S.S., Stanko J.P., Gibbs-Flournoy E.A., Lau C., Fenton S.E. Phenotypic dichotomy following developmental exposure to perfluorooctanoic acid (PFOA) in female CD-1 mice: Low doses induce elevated serum leptin and insulin, and overweight in mid-life. Mol. Cell. Endocrinol. 2009, 304:97-105.
22. Janesick A., Blumberg B. Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity. Birth Defects Res. C 2011, 93:34-50.
23. Johansson N., Fredriksson A., Eriksson P. Neonatal exposure to perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) causes neurobehavioural defects in adult mice. Neurotoxicology 2008, 29:160-169.
24. Kärrman A., Harada K.H., Inoue K., Takasuga T., Ohi E., Koizumi A. Relationship between dietary exposure and serum perfluorochemical (PFC) levels - a case study. Environ. Int. 2009, 35:712-717.
25. Kennedy G.L., Butenhoff J.L., Olsen G.W., O'Connor J.C., Seacat A.M., Perkins R.G., Biegel L.B., Murphy S.R., Farrar D.G. The toxicology of perfluorooctanoate. Crit. Rev. Toxicol. 2004, 34:351-384.
26. Klaunig J.E., Hocevar B.A., Kamendulis L.M. Mode of Action analysis of perfluorooctanoic acid (PFOA) tumorigenicity and Human Relevance. Reprod. Toxicol. 2012, 33:410-418.
27. Lau C., Anitole K., Hodes C., Lai D., Pfahles-Hutchens A., Seed J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol. Sci. 2007, 99:366-394.
28. Lau C., Butenhoff J.L., Rogers J.M. The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol. Appl. Pharmacol. 2004, 198:231-241.
29. Lau C., Thibodeaux J.R., Hanson R.G., Narotsky M.G., Rogers J.M., Lindstrom A.B., Strynar M.J. Effects of perfluorooctanoic acid exposure during pregnancy in the mouse. Toxicol. Sci. 2006, 90:510-518.
30. Lau C., Thibodeaux J.R., Hanson R.G., Rogers J.M., Grey B.E., Stanton M.E., Butenhoff J.L., Stevenson L.A. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation. Toxicol. Sci. 2003, 74:382-392.
31. Lin C.Y., Chen P.C., Lin Y.C., Lin L.Y. Association among serum perfluoroalkyl chemicals, glucose homeostasis, and metabolic syndrome in adolescents and adults. Diabetes Care 2009, 32:702-707.
32. Lv Z., Li G., Li Y., Ying C., Chen J., Chen T., Wei J., Lin Y., Jiang Y., Wang Y., Shu B., Xu B., Xu S. Glucose and lipid homeostasis in adult rat is impaired by early-life exposure to perfluorooctane sulfonate. Environ. Toxicol. 2013, 28:532-542.
33. Midasch O., Drexler H., Hart N., Beckmann M.W., Angerer J. Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study. Int. Arch. Occup. Environ. Health 2007, 80:643-648.
34. Moser A.R., Pitot H.C., Dove W.F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 1990, 247:322-324.
35. Olsen G.W., Burris J.M., Ehresman D.J., Froehlich J.W., Seacat A.M., Butenhoff J.L., Zobel L.R. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ. Health Perspect. 2007, 115:1298-1305.
36. Post G.B., Cohn P.D., Cooper K.R. Perfluorooctanoic acid (PFOA), an emerging drinking water contaminant: a critical review of recent literature. Environ. Res. 2012, 116:93-117.
37. Rexhepaj R., Rotte A., Gu S., Michael D., Pasham V., Wang K., Kempe D.S., Ackermann T.F., Brucher B., Fend F., Foller M., Lang F. Tumor suppressor gene adenomatous polyposis coli downregulates intestinal transport. Pflug. Arch. Eur. J. Phy. 2011, 461:527-536.
38. Schug T.T., Janesick A., Blumberg B., Heindel J.J. Endocrine disrupting chemicals and disease susceptibility. J. Steroid Biochem. Mol. Biol. 2011, 127:204-215.
39. Soto A.M., Sonnenschein C. Environmental causes of cancer: endocrine disruptors as carcinogens. Nat. Rev. Endocrinol. 2010, 6:363-370.
40. Su L.K., Kinzler K.W., Vogelstein B., Preisinger A.C., Moser A.R., Luongo C., Gould K.A., Dove W.F. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 1992, 256:668-670.
41. Thibodeaux J.R., Hanson R.G., Rogers J.M., Grey B.E., Barbee B.D., Richards J.H., Butenhoff J.L., Stevenson L.A., Lau C. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations. Toxicol. Sci. 2003, 74:369-381.
42. Yang C., Tan Y.S., Harkema J.R., Haslam S.Z. Differential effects of peripubertal exposure to perfluorooctanoic acid on mammary gland development in C57Bl/6 and Balb/c mouse strains. Reprod. Toxicol. 2009, 27:299-306.